MyBiotech provides comprehensive Quality Control and stability testing services to ensure full understanding and control of critical material attributes (CMAs), critical quality attributes (CQAs) and long-term stability of nanoparticle drug products. Our analytical approach supports development, clinical manufacturing and regulatory submissions with phase-appropriate, ICH-compliant and GMP-aligned validation strategies. Using robust methods and clear specifications, we enable comparability, data trending and confident release decisions.
